Buckingham Strategic Wealth’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$55.1K Buy
17,820
+100
+0.6% +$300 ﹤0.01% 751
2024
Q1
$45.7K Hold
17,720
﹤0.01% 746
2023
Q4
$44.3K Hold
17,720
﹤0.01% 713
2023
Q3
$36K Hold
17,720
﹤0.01% 680
2023
Q2
$40.8K Hold
17,720
﹤0.01% 682
2023
Q1
$41.3K Hold
17,720
﹤0.01% 604
2022
Q4
$41.3K Hold
17,720
﹤0.01% 606
2022
Q3
$34K Sell
17,720
-11
-0.1% -$26 ﹤0.01% 592
2022
Q2
$48K Buy
17,731
+11
+0.1% +$28 ﹤0.01% 587
2022
Q1
$53K Buy
17,720
+5,000
+39% +$15.3K ﹤0.01% 585
2021
Q4
$49K Hold
12,720
﹤0.01% 588
2021
Q3
$55K Buy
12,720
+1,000
+9% +$3.33K ﹤0.01% 583
2021
Q2
$36K Buy
+11,720
New +$36.3K ﹤0.01% 585

Other funds holding ABUS